{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:23:23Z","timestamp":1774049003078,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316803389- SFB 1280 (TP A18)"],"award-info":[{"award-number":["316803389- SFB 1280 (TP A18)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316803389- SFB 1280 (TP A18)"],"award-info":[{"award-number":["316803389- SFB 1280 (TP A18)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Calcineurin is a protein regulating cytokine expression in T lymphocytes and calcineurin inhibitors such as cyclosporine A (CsA) are widely used for immunosuppressive therapy. It also plays a functional role in distinct neuronal processes in the central nervous system. Disturbed information processing as seen in neuropsychiatric disorders is reflected by deficient sensorimotor gating, assessed as prepulse inhibition (PPI) of the acoustic startle response (ASR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Patients who require treatment with immunosuppressive drugs frequently display neuropsychiatric alterations during treatment with calcineurin inhibitors. Importantly, knockout of calcineurin in the forebrain of mice is associated with cognitive impairments and symptoms of schizophrenia-like psychosis as seen after treatment with stimulants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The present study investigated in rats effects of systemic acute and subchronic administration of CsA on sensorimotor gating. Following a single injection with effective doses of CsA, adult healthy male Dark Agouti rats were tested for PPI. For subchronic treatment, rats were injected daily with the same doses of CsA for 1\u00a0week before PPI was assessed. Since calcineurin works as a modulator of the dopamine pathway, activity of the enzyme tyrosine hydroxylase was measured in the prefrontal cortex and striatum after accomplishment of the study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Acute and subchronic treatment with the calcineurin inhibitor CsA disrupted PPI at a dose of 20\u00a0mg\/kg. Concomitantly, following acute CsA treatment, tyrosine hydroxylase activity was reduced in the prefrontal cortex, which suggests that dopamine synthesis was downregulated, potentially reflecting a stimulatory impact of CsA on this neurotransmitter system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results support experimental and clinical evidence linking impaired calcineurin signaling in the central nervous system to the pathophysiology of neuropsychiatric symptoms. Moreover, these findings suggest that therapy with calcineurin inhibitors may be a risk factor for developing neurobehavioral alterations as observed after the abuse of psychomotor stimulant drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00213-020-05751-1","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T22:02:49Z","timestamp":1608588169000},"page":"1047-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats"],"prefix":"10.1007","volume":"238","author":[{"given":"Jan","family":"Brosda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathis","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Jakobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"H\u00f6rbelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Bendix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"L\u00fcckemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Schedlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hadamitzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"5751_CR1","doi-asserted-by":"crossref","unstructured":"Abi-Dargham A, Moore H (2016) Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9:404\u2013416","DOI":"10.1177\/1073858403252674"},{"key":"5751_CR2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-008-1189-5","volume":"200","author":"NA Addy","year":"2008","unstructured":"Addy NA, Bahi A, Taylor JR, Picciotto MR (2008) Administration of the calcineurin inhibitor cyclosporine modulates cocaine-induced locomotor activity in rats. Psychopharmacology 200:129\u2013139","journal-title":"Psychopharmacology"},{"key":"5751_CR3","doi-asserted-by":"crossref","unstructured":"Batiuk TD, Halloran PF (1997) The downstream consequences of calcineurin inhibition. Transplant Proc 29:1239\u20131240","DOI":"10.1016\/S0041-1345(96)00481-2"},{"key":"5751_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41390-018-0222-6","volume":"85","author":"I Bendix","year":"2019","unstructured":"Bendix I, Hadamitzky M, Herz J, Felderhoff-M\u00fcser U (2019) Adverse neuropsychiatric development following perinatal brain injury: from a preclinical perspective. Pediatr Res 85:198\u2013215","journal-title":"Pediatr Res"},{"key":"5751_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuropharm.2014.12.008","volume":"96","author":"K Bosche","year":"2015","unstructured":"Bosche K, Weissenborn K, Christians U, Witzke O, Engler H, Schedlowski M, Hadamitzky M (2015) Neurobehavioral consequences of small molecule-drug immunosuppression. Neuropharmacology 96:83\u201393","journal-title":"Neuropharmacology"},{"key":"5751_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(00)00139-0","volume":"49","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR (2001) Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49:171\u2013178","journal-title":"Schizophr Res"},{"key":"5751_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nbd.2011.07.008","volume":"44","author":"J Brosda","year":"2011","unstructured":"Brosda J, Dietz F, Koch M (2011) Impairment of cognitive performance after reelin knockdown in the medial prefrontal cortex of pubertal or adult rats. Neurobiol Dis 44:239\u2013247","journal-title":"Neurobiol Dis"},{"key":"5751_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-006-0380-9","volume":"186","author":"SC Brunell","year":"2006","unstructured":"Brunell SC, Spear LP (2006) Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats. Psychopharmacology 186:579\u2013586","journal-title":"Psychopharmacology"},{"key":"5751_CR9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1176\/appi.ajp.159.5.869","volume":"159","author":"KS Cadenhead","year":"2002","unstructured":"Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL (2002) Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? Am J Psychiatry 159:869\u2013871","journal-title":"Am J Psychiatry"},{"key":"5751_CR10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0006-3223(94)00378-5","volume":"38","author":"RJ Carey","year":"1995","unstructured":"Carey RJ, Pinheiro-Carrera M, Dai H, Tomaz C, Huston JP (1995) L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone. Biol Psychiatry 38:669\u2013676","journal-title":"Biol Psychiatry"},{"key":"5751_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-003-1710-9","volume":"174","author":"SA Castner","year":"2004","unstructured":"Castner SA, Goldman-Rakic PS, Williams GV (2004) Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 174:111\u2013125","journal-title":"Psychopharmacology"},{"key":"5751_CR12","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0041-1345(01)02510-6","volume":"33","author":"SH Chang","year":"2001","unstructured":"Chang SH, Lim CS, Low TS, Chong HT, Tan SY (2001) Cyclosporine-associated encephalopathy: a case report and literature review. Transplant Proc 33:3700\u20133701","journal-title":"Transplant Proc"},{"key":"5751_CR13","first-page":"37","volume-title":"Brain microdissection techniques","author":"AC Cuello","year":"1983","unstructured":"Cuello AC, Carson S (1983) Microdissection of fresh rat brain tissue slices. In: Cuello AC (ed) Brain microdissection techniques. Wiley, New York, pp 37\u2013125"},{"key":"5751_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508:1\u201312","journal-title":"Arch Biochem Biophys"},{"key":"5751_CR15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM198710013171404","volume":"317","author":"PC de Groen","year":"1987","unstructured":"de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA (1987) Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 317:861\u2013866","journal-title":"N Engl J Med"},{"key":"5751_CR16","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274\u20135278","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5751_CR17","doi-asserted-by":"crossref","unstructured":"Dimitrijevi\u0107 M, Arsenovi\u0107-Ranin N, Bufan B, Nacka-Aleksi\u0107 M, Macanovi\u0107 ML, Milovanovi\u0107 P, \u0110uri\u0107 M, Sopta J, Leposavi\u0107 G (2018) Collagen-induced arthritis in Dark Agouti rats as a model for study of immunological sexual dimorphisms in the human disease. Exp Mol Pathol 105:10\u201322","DOI":"10.1016\/j.yexmp.2018.05.007"},{"key":"5751_CR18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.neuroscience.2008.07.052","volume":"156","author":"LK Dobbs","year":"2008","unstructured":"Dobbs LK, Mark GP (2008) Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse. Neuroscience 156:700\u2013711","journal-title":"Neuroscience"},{"key":"5751_CR19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s002130050513","volume":"135","author":"JP Druhan","year":"1998","unstructured":"Druhan JP, Geyer MA, Valentino RJ (1998) Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology 135:296\u2013304","journal-title":"Psychopharmacology"},{"key":"5751_CR20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","volume":"31","author":"RE Featherstone","year":"2007","unstructured":"Featherstone RE, Kapur S, Fletcher PJ (2007) The amphetamine-induced sensitized state as a model of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 31:1556\u20131571","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5751_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00213-005-0157-6","volume":"183","author":"PJ Fletcher","year":"2005","unstructured":"Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S (2005) Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology 183:190\u2013200","journal-title":"Psychopharmacology"},{"key":"5751_CR22","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1073\/pnas.1432927100","volume":"100","author":"DJ Gerber","year":"2003","unstructured":"Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S (2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A 100:8993\u20138998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5751_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117\u2013154","journal-title":"Psychopharmacology"},{"key":"5751_CR24","doi-asserted-by":"crossref","unstructured":"Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 21:247\u2013269","DOI":"10.1023\/A:1013205230142"},{"key":"5751_CR25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2010.11.009","volume":"217","author":"M Hadamitzky","year":"2011","unstructured":"Hadamitzky M, Markou A, Kuczenski R (2011) Extended access to methamphetamine self-administration affects sensorimotor gating in rats. Behav Brain Res 217:386\u2013390","journal-title":"Behav Brain Res"},{"key":"5751_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbr.2014.06.056","volume":"273","author":"M Hadamitzky","year":"2014","unstructured":"Hadamitzky M, Herring A, Keyvani K, Doenlen R, Krugel U, Bosche K, Orlowski K, Engler H, Schedlowski M (2014) Acute systemic rapamycin induces neurobehavioral alterations in rats. Behav Brain Res 273:16\u201322","journal-title":"Behav Brain Res"},{"key":"5751_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2015.09.009","volume":"52","author":"M Hadamitzky","year":"2016","unstructured":"Hadamitzky M, Bosche K, Wirth T, Buck B, Beetz O, Christians U, Schniedewind B, Luckemann L, Gunturkun O, Engler H, Schedlowski M (2016) Memory-updating abrogates extinction of learned immunosuppression. Brain Behav Immun 52:40\u201348","journal-title":"Brain Behav Immun"},{"key":"5751_CR28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ijnp\/pyy017","volume":"21","author":"M Hadamitzky","year":"2018","unstructured":"Hadamitzky M, Herring A, Kirchhof J, Bendix I, Haight MJ, Keyvani K, Luckemann L, Unteroberdorster M, Schedlowski M (2018) Repeated systemic treatment with rapamycin affects behavior and amygdala protein expression in rats. Int J Neuropsychopharmacol 21:592\u2013602","journal-title":"Int J Neuropsychopharmacol"},{"key":"5751_CR29","doi-asserted-by":"crossref","unstructured":"Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715\u20132729","DOI":"10.1056\/NEJMra033540"},{"key":"5751_CR30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1471-4159.1996.67020629.x","volume":"67","author":"WJ Harada","year":"1996","unstructured":"Harada WJ, Haycock JW, Goldstein M (1996) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme. J Neurochem 67:629\u2013635","journal-title":"J Neurochem"},{"key":"5751_CR31","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi00430a066","volume":"28","author":"MJ Hubbard","year":"1989","unstructured":"Hubbard MJ, Klee CB (1989) Functional domain structure of calcineurin A: mapping by limited proteolysis. Biochemistry 28:1868\u20131874","journal-title":"Biochemistry"},{"key":"5751_CR32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s002130050964","volume":"143","author":"KE Hutchison","year":"1999","unstructured":"Hutchison KE, Swift R (1999) Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology 143:394\u2013400","journal-title":"Psychopharmacology"},{"key":"5751_CR33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1471-4159.2002.00982.x","volume":"82","author":"JP Jedynak","year":"2002","unstructured":"Jedynak JP, Ali SF, Haycock JW, Hope BT (2002) Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J Neurochem 82:382\u2013388","journal-title":"J Neurochem"},{"key":"5751_CR34","first-page":"3082","volume":"26","author":"BD Kahan","year":"1994","unstructured":"Kahan BD (1994) Role of cyclosporine: present and future. Transplant Proc 26:3082\u20133087","journal-title":"Transplant Proc"},{"key":"5751_CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00007890-198702000-00007","volume":"43","author":"BD Kahan","year":"1987","unstructured":"Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT (1987) Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 43:197\u2013204","journal-title":"Transplantation"},{"key":"5751_CR36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41398-017-0071-9","volume":"8","author":"JP Kesby","year":"2018","unstructured":"Kesby JP, Eyles DW, McGrath JJ, Scott JG (2018) Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry 8:30","journal-title":"Transl Psychiatry"},{"key":"5751_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-0082(98)00098-7","volume":"59","author":"M Koch","year":"1999","unstructured":"Koch M (1999) The neurobiology of startle. Prog Neurobiol 59:107\u2013128","journal-title":"Prog Neurobiol"},{"key":"5751_CR38","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","volume":"41","author":"UE Lang","year":"2009","unstructured":"Lang UE, Heger J, Willbring M, Domula M, Matschke K, Tugtekin SM (2009) Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement. Transplant Proc 41:4285\u20134288","journal-title":"Transplant Proc"},{"key":"5751_CR39","doi-asserted-by":"crossref","unstructured":"Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia. Ann N Y Acad Sci 1003:138\u2013158","DOI":"10.1196\/annals.1300.063"},{"key":"5751_CR40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0028-3908(77)90046-6","volume":"16","author":"BE Leonard","year":"1977","unstructured":"Leonard BE (1977) Drug-induced changes in brain tyrosine hydroxylase activity in vivo. Neuropharmacology 16:47\u201352","journal-title":"Neuropharmacology"},{"key":"5751_CR41","first-page":"851","volume":"10","author":"Y Lin","year":"2007","unstructured":"Lin Y, Sun IW, Liu SI, Lohel W, Lin YC (2007) Tacrolimus ointment-induced relapse of schizophrenia: a case report. Int J Neuropsychopharmacol 10:851\u2013854","journal-title":"Int J Neuropsychopharmacol"},{"key":"5751_CR42","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","volume":"110","author":"J Lindenfeld","year":"2004","unstructured":"Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J (2004) Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation 110:3734\u20133740","journal-title":"Circulation"},{"key":"5751_CR43","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1046\/j.1471-4159.2000.0742470.x","volume":"74","author":"N Lindgren","year":"2000","unstructured":"Lindgren N, Xu ZQ, Lindskog M, Herrera-Marschitz M, Goiny M, Haycock J, Goldstein M, H\u00f6kfelt T, Fisone G (2000) Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum. J Neurochem 74:2470\u20132477","journal-title":"J Neurochem"},{"key":"5751_CR44","doi-asserted-by":"crossref","unstructured":"Liu J, Albers MW, Wandless TJ, Luan S, Alberg DG, Belshaw PJ, Cohen P, MacKintosh C, Klee CB, Schreiber SL (1992) Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31:3896\u20133901","DOI":"10.1021\/bi00131a002"},{"key":"5751_CR45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/art.41101","volume":"72","author":"L L\u00fcckemann","year":"2020","unstructured":"L\u00fcckemann L, Stangl H, Straub RH, Schedlowski M, Hadamitzky M (2020) Learned immunosuppressive placebo response attenuates disease progression in a rodent model of rheumatoid arthritis. Arthritis Rheumatol 72:588\u2013597","journal-title":"Arthritis Rheumatol"},{"key":"5751_CR46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00212846","volume":"94","author":"RS Mansbach","year":"1988","unstructured":"Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507\u2013514","journal-title":"Psychopharmacology"},{"key":"5751_CR47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.biopsych.2014.03.009","volume":"75","author":"YS Mineur","year":"2014","unstructured":"Mineur YS, Taylor SR, Picciotto MR (2014) Calcineurin downregulation in the amygdala is sufficient to induce anxiety-like and depression-like behaviors in C57BL\/6J male mice. Biol Psychiatry 75:991\u2013998","journal-title":"Biol Psychiatry"},{"key":"5751_CR48","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1073\/pnas.1432926100","volume":"100","author":"T Miyakawa","year":"2003","unstructured":"Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 100:8987\u20138992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5751_CR49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S1461145711001799","volume":"16","author":"G Pacheco-Lopez","year":"2013","unstructured":"Pacheco-Lopez G, Doenlen R, Krugel U, Arnold M, Wirth T, Riether C, Engler A, Niemi MB, Christians U, Engler H, Schedlowski M (2013) Neurobehavioural activation during peripheral immunosuppression. Int J Neuropsychopharmacol 16:137\u2013149","journal-title":"Int J Neuropsychopharmacol"},{"key":"5751_CR50","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson S (1998) The rat brain in stereotaxic coordinates. Academic, San Diego"},{"key":"5751_CR51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00421062","volume":"41","author":"AJ Pijnenburg","year":"1975","unstructured":"Pijnenburg AJ, Honig WM, Van Rossum JM (1975) Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia 41:87\u201395","journal-title":"Psychopharmacologia"},{"key":"5751_CR52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2007.01.017","volume":"26","author":"M Rothenburger","year":"2007","unstructured":"Rothenburger M, Teerling E, Bruch C, Lehmkuhl H, Suwelack B, Bara C, Wichter T, Hinder F, Schmid C, Stypmann J (2007) Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months\u2019 follow-up. J Heart Lung Transplant 26:250\u2013257","journal-title":"J Heart Lung Transplant"},{"key":"5751_CR53","doi-asserted-by":"crossref","unstructured":"Rusnak F, Mertz P (2000) Calcineurin: form and function. Physiol Rev 80:1483\u20131521","DOI":"10.1152\/physrev.2000.80.4.1483"},{"key":"5751_CR54","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/01.tp.0000263332.65519.1f","volume":"83","author":"Y Sato","year":"2007","unstructured":"Sato Y, Takayanagi Y, Onaka T, Kobayashi E (2007) Impact of cyclosporine upon emotional and social behavior in mice. Transplantation 83:1365\u20131370","journal-title":"Transplantation"},{"key":"5751_CR55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2018.04.019","volume":"348","author":"KH Struntz","year":"2018","unstructured":"Struntz KH, Siegel JA (2018) Effects of methamphetamine exposure on anxiety-like behavior in the open field test, corticosterone, and hippocampal tyrosine hydroxylase in adolescent and adult mice. Behav Brain Res 348:211\u2013218","journal-title":"Behav Brain Res"},{"key":"5751_CR56","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","volume":"69","author":"D Sulzer","year":"2011","unstructured":"Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69:628\u2013649","journal-title":"Neuron"},{"key":"5751_CR57","doi-asserted-by":"crossref","unstructured":"Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacology Biochemistry and Behavior 44:741\u2013744","DOI":"10.1016\/0091-3057(93)90193-W"},{"key":"5751_CR58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","volume":"51","author":"NR Swerdlow","year":"1994","unstructured":"Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139\u2013154","journal-title":"Arch Gen Psychiatry"},{"key":"5751_CR59","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1523\/JNEUROSCI.20-11-04325.2000","volume":"20","author":"NR Swerdlow","year":"2000","unstructured":"Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA (2000) Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20:4325\u20134336","journal-title":"J Neurosci"},{"key":"5751_CR60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","volume":"156","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194\u2013215","journal-title":"Psychopharmacology"},{"key":"5751_CR61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0952-7915(00)00269-7","volume":"13","author":"PC Taylor","year":"2001","unstructured":"Taylor PC, Williams RO, Maini RN (2001) Immunotherapy for rheumatoid arthritis. Curr Opin Immunol 13:611\u2013616","journal-title":"Curr Opin Immunol"},{"key":"5751_CR62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1196\/annals.1377.008","volume":"1086","author":"K Takao","year":"2006","unstructured":"Takao K, Miyakawa T (2006) Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice. Ann N Y Acad Sci 1086:144\u2013159","journal-title":"Ann N Y Acad Sci"},{"key":"5751_CR63","doi-asserted-by":"crossref","unstructured":"Tedesco D, Haragsim L (2012) Cyclosporine: a review. J Transplant 2012: 230386.","DOI":"10.1155\/2012\/230386"},{"key":"5751_CR64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0920-9964(03)00009-4","volume":"64","author":"CC Tenn","year":"2003","unstructured":"Tenn CC, Fletcher PJ, Kapur S (2003) Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64:103\u2013114","journal-title":"Schizophr Res"},{"key":"5751_CR65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0091-3057(97)00467-X","volume":"60","author":"S von Horsten","year":"1998","unstructured":"von Horsten S, Exton MS, Voge J, Schult M, Nagel E, Schmidt RE, Westermann J, Schedlowski M (1998) Cyclosporine A affects open field behavior in DA rats. Pharmacol Biochem Behav 60:71\u201376","journal-title":"Pharmacol Biochem Behav"},{"key":"5751_CR66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35081514","volume":"2","author":"DG Winder","year":"2001","unstructured":"Winder DG, Sweatt JD (2001) Roles of serine\/threonine phosphatases in hippocampel synaptic plasticity. Nat Rev Neurosci 2:461\u2013474","journal-title":"Nat Rev Neurosci"},{"key":"5751_CR67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0092-8674(01)00585-2","volume":"107","author":"H Zeng","year":"2001","unstructured":"Zeng H, Chattarji S, Barbarosie M, Rondi-Reig L, Philpot BD, Miyakawa T, Bear MF, Tonegawa S (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working\/episodic-like memory. Cell 107:617\u2013629","journal-title":"Cell"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05751-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-020-05751-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05751-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T09:18:16Z","timestamp":1615972696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-020-05751-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5751"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05751-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}